Zakrzewski Joseph S 4
4 · Cyteir Therapeutics, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Purchase
Common Stock
2022-05-12$1.61/sh+743$1,196→ 133,416 total
Holdings
- 58,671(indirect: See Footnote)
Common Stock
- 149,051(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]55,102 of the shares of common stock held directly and indirectly by the Reporting Person were acquired upon early exercise of an option and are subject to forfeiture until they vest.
- [F2]Shares held by Z Investments, LLC, of which the Reporting Person is the Managing Director. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.
- [F3]Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.